Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/24083
Title: | Smartphone applications for educating and helping non-motivating patients adhere to medication that treats mental health conditions: Aims and functioning | Authors: | Kassianos, Angelos P. Georgiou, Giorgos Papaconstantinou, Electra P. Detzortzi, Angeliki Horne, Rob |
Major Field of Science: | Medical and Health Sciences | Field Category: | Other Medical Sciences | Keywords: | Adherence;Psychotropic;mHealth;Smartphone;Compliance;Health education;Mental health;Digital health | Issue Date: | 11-Oct-2017 | Source: | Frontiers in Psychology, 2017, vol. 8, articl. no. 1769 | Volume: | 8 | Journal: | Frontiers in Psychology | Abstract: | Background: Patients prescribed with medication that treats mental health conditions benefit the most compared to those prescribed with other types of medication. However, they are also the most difficult to adhere. The development of mobile health (mHealth) applications ("apps") to help patients monitor their adherence is fast growing but with limited evidence on their efficacy. There is no evidence on the content of these apps for patients taking psychotropic medication. The aim of this study is to identify and evaluate the aims and functioning of available apps that are aiming to help and educate patients to adhere to medication that treats mental health conditions. Method: Three platform descriptions (Apple, Google, and Microsoft) were searched between October 2015 and February 2016. Included apps need to focus on adherence to medication that treats mental health conditions and use at least a reinforcement strategy. Descriptive information was extracted and apps evaluated on a number of assessment criteria using content analysis. Results: Sixteen apps were identified. All apps included self-monitoring properties like reminders and psycho-educational properties like mood logs. It was unclear how the latter were used or how adherence was measured. Major barriers to medication adherence like patients' illness and medication beliefs and attitudes were not considered nor where information to patients about mediation side effects. Very few apps were tailored and none was developed based on established theories explaining the processes for successful medication adherence like cognitions and beliefs. Reported information on app development and validation was poor. Discussion: A variety of apps with different properties that tackle both intentional and unintentional non-adherence from a different perspective are identified. An evidence-based approach and co-creation with patients is needed. This will ensure that the apps increase the possibility to impact on non-adherence. Theories like social cognition models can be useful in ensuring that patients' education, motivation, skills, beliefs, and type of adherence are taken into consideration when developing the apps. Findings from this study can help clinicians and patients make informed choices and pursue policy-makers to integrate evidence when developing future apps. Quality-assurance tools are needed to ensure the apps are systematically evaluated. | URI: | https://hdl.handle.net/20.500.14279/24083 | ISSN: | 16641078 | DOI: | 10.3389/fpsyg.2017.01769 | Rights: | © The Author(s). | Type: | Article | Affiliation : | University College London University of Cyprus Cyprus Institute of Neurology and Genetics |
Publication Type: | Peer Reviewed |
Appears in Collections: | Άρθρα/Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fpsyg_08_01769_pdf.pdf | 720.18 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
12
checked on Feb 1, 2024
WEB OF SCIENCETM
Citations
10
Last Week
0
0
Last month
0
0
checked on Oct 29, 2023
Page view(s)
222
Last Week
0
0
Last month
2
2
checked on Nov 6, 2024
Download(s)
150
checked on Nov 6, 2024
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License